Clinical Trials Logo

Aesthetics clinical trials

View clinical trials related to Aesthetics.

Filter by:
  • None
  • Page 1

NCT ID: NCT05747456 Recruiting - Aging Clinical Trials

Study of a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face (FaceHyal)

FaceHyal
Start date: February 22, 2023
Phase: N/A
Study type: Interventional

The primary objective of the study is to demonstrate the superiority of IPN-21-SENSE versus no treatment at 24 weeks after baseline for the creation or restoration of volume deficit in the mid-face.

NCT ID: NCT05355454 Active, not recruiting - Aging Clinical Trials

Study of STYLAGE® XXL for Volume Deficiency in the Mid-Face

MidFaceXXL
Start date: June 6, 2022
Phase: N/A
Study type: Interventional

The primary objective of the study is to demonstrate the superiority of STYLAGE® XXL versus no treatment at 24 weeks after baseline for the creation or restoration of volume deficit in the mid-face.

NCT ID: NCT04505319 Completed - Aesthetics Clinical Trials

Clinical Evaluation of the Safety and Performance of a Filler in Correction of Mid-face Age-related Volume Deficit

Start date: September 14, 2020
Phase: N/A
Study type: Interventional

Prospective, single center study, on healthy subjects to evaluate the aesthetic improvement of facial volume, effect on the restoration and/or augmentation in subjects with mid-face age-related volume deficit after injection of a filler with lidocaine.

NCT ID: NCT02703740 Completed - Aesthetics Clinical Trials

Long Term Safety and Efficacy Assessment of Hyaluronic Acid Dermal Filler With for the Treatment of Nasolabial Folds

ECLAH
Start date: January 11, 2016
Phase: N/A
Study type: Interventional

This study evaluates the injection of a hyaluronic acid dermal filler with lidocaine 0.3% in the treatment of nasolabial folds (NLF). Each patient will receive 1 concentration in a NLF (20 mg/mL) and an other concentration in the other NLF (24 mg/mL).

NCT ID: NCT02297516 Completed - Aesthetics Clinical Trials

Safety and Efficacy of Azzalure/Dysport, Restylane/Emervel Filler and Restylane Skinbooster Treatment

Start date: November 2014
Phase: Phase 4
Study type: Interventional

The efficacy and safety, as well as subject satisfaction will be evaluated after single treatment with Azzalure/Dysport alone or Restylane/Emervel filler alone followed by repeated combined treatment with Azzalure/Dysport, Restylane/Emervel filler and Restylane Skinbooster. Subjects will be followed for up to 18 months after initial treatment.

NCT ID: NCT01412190 Completed - Aesthetics Clinical Trials

Study to Evaluate Restylane Vital Light Using an Injector Device

Start date: April 2009
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the safety and efficacy of Restylane Vital White administered with an injector device on aged skin in the face, hands and décolletage.

NCT ID: NCT00845078 Withdrawn - Radiotherapy Clinical Trials

Prospective Outcomes After Reconstruction and Radiotherapy for Breast Cancer

Start date: December 2008
Phase: N/A
Study type: Observational

This study examines the aesthetic outcomes of breast reconstruction after mastectomy for breast cancer in patients who require post-mastectomy radiation treatment. Patients will undergo autologous tissue breast reconstruction either in immediate fashion, prior to radiation treatment, or in delayed fashion, after radiation treatment. Both approaches are acceptable and are practiced clinically. this will be an observational prospective cohort study. The investigators hypothesize that immediate autologous reconstruction patients who undergo subsequent radiation therapy have equivalent aesthetic outcome when compared to those in whom reconstruction is delayed until after radiation, with the additional benefit of avoiding the psychological side effects of breast amputation.